Featured Topics
Calendar

March 05, 2025

FY/Q4 2024 Results / Annual Report
ESG Report 2024

April 25, 2025

Annual Stockholders’ Meeting 2025
Press Releases
Share Price / Index
January 14, 2025
Not intended for U.S. and UK Media
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline Advances
January 13, 2025
Not intended for UK Media
BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial
January 10, 2025
Not intended for U.S. and UK Media
Bayer submits application to U.S. FDA and to China’s CDE for new indication of finerenone for patients with common form of heart failure with high unmet medical need

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.